Gleason Group’s Privia Health PRVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-2,150
Closed -$49.5K 231
2023
Q3
$49.5K Hold
2,150
0.01% 119
2023
Q2
$56.1K Hold
2,150
0.01% 115
2023
Q1
$59.4K Hold
2,150
0.02% 105
2022
Q4
$48.8K Hold
2,150
0.02% 112
2022
Q3
$73K Hold
2,150
0.03% 95
2022
Q2
$63K Hold
2,150
0.02% 102
2022
Q1
$57K Buy
+2,150
New +$50.8K 0.02% 111

Other funds holding PRVA

Gleason Group's PRVA Position: Q4 2023 in Review

Gleason Group sold out of Privia Health (PRVA) in Q4 2023, closing a stake of 2,150 shares — an estimated $49.5K sold.

Gleason Group first reported a position in PRVA in Q1 2022 and held it in 7 quarters. The position peaked at $73K in Q3 2022. 226 funds tracked by Wall St. Rank hold PRVA as of Q4 2023.

  • Gleason Group reported no remaining Privia Health position as of Q4 2023 after selling out during the quarter.
  • Gleason Group sold 2,150 Privia Health shares in Q4 2023, an estimated $49.5K.
  • Gleason Group first reported a position in Privia Health in Q1 2022 and held it in 7 quarters.
  • Gleason Group's Privia Health position peaked at $73K in Q3 2022.
  • 226 funds tracked by Wall St. Rank held Privia Health as of Q4 2023.

Based on Gleason Group's 13F filing for Q4 2023, filed 19 Jan 2024.